Bellevue Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $7.99M | Hold |
|
|||||
|
2024
Q3 | $16.9M | Hold |
|
|||||
|
2024
Q2 | $15.9M | Hold |
|
|||||
|
2024
Q1 | $35.5M | Sell |
|
|||||
|
2023
Q4 | $18.1M | Hold |
|
|||||
|
2023
Q3 | $10.3M | Sell |
|
|||||
|
2023
Q2 | $23.1M | Hold |
|
|||||
|
2023
Q1 | $27.7M | Sell |
|
|||||
|
2022
Q4 | $49.1M | Buy |
|
|||||
|
2022
Q3 | $84M | Buy |
|
|||||
|
2022
Q2 | $88M | Sell |
|
|||||
|
2022
Q1 | $139M | Sell |
|
|||||
|
2021
Q4 | $221M | Buy |
|
|||||
|
2021
Q3 | $192M | Buy |
|
|||||
|
2021
Q2 | $227M | Buy |
|
|||||
|
2021
Q1 | $182M | Buy |
|
|||||
|
2020
Q4 | $192M | Sell |
|
|||||
|
2020
Q3 | $88.6M | Buy |
|
|||||
|
2020
Q2 | $67.3M | Buy |
|
|||||
|
2020
Q1 | $34.7M | Buy |
|
|||||
|
2019
Q4 | $1.62M | Buy |
|
|||||
|
2019
Q3 | $933K | Buy |
|
|||||
|
2019
Q2 | $1.2M | Buy |
|